RACHEL SCHIFF to Dasatinib
This is a "connection" page, showing publications RACHEL SCHIFF has written about Dasatinib.
Connection Strength
0.036
-
Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. Breast Cancer Res. 2020 08 08; 22(1):84.
Score: 0.036
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.